SPAGO Nanomedical AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SPAGO Nanomedical AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10582
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Spago Nanomedical AB (Spago Nanomedical), formerly Spago Imaging AB is a research and development company that develops nanomedical products for the diagnosis and treatment of cancer. The company offers spagopix, a magnetic resonance imaging contrast agent to improve the visualization of soft tissue tumors and metastases; and tumorad, a nanomedical therapeutic agent loaded with radioactive isotopes in order to enable internal tumor selective radiotherapy. It uses its internally developed technologies as therapeutics, diagnostics, theranostics and drug delivery agents. The company caters to pharmaceutical industry for discovery research, early clinical application and business development. Spago Nanomedical is headquartered in Lund, Sweden.

SPAGO Nanomedical AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SPAGO Nanomedical AB, Medical Devices Deals, 2012 to YTD 2018 9
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
SPAGO Nanomedical Raises USD1 Million in Private Placement of Shares 11
Equity Offering 12
SPAGO Nanomedical Raises USD5.9 Million in Rights Offering of Shares 12
Spago Nanomedical Raises USD3 Million in Rights Issue of Shares 13
SPAGO Nanomedical AB – Key Competitors 14
SPAGO Nanomedical AB – Key Employees 15
SPAGO Nanomedical AB – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
Mar 22, 2017: Anna Sundlov Nominated to the Board of Directors in Spago Nanomedical 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Key Facts 2
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SPAGO Nanomedical AB, Deals By Therapy Area, 2012 to YTD 2018 8
SPAGO Nanomedical AB, Medical Devices Deals, 2012 to YTD 2018 9
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
SPAGO Nanomedical Raises USD1 Million in Private Placement of Shares 11
SPAGO Nanomedical Raises USD5.9 Million in Rights Offering of Shares 12
Spago Nanomedical Raises USD3 Million in Rights Issue of Shares 13
SPAGO Nanomedical AB, Key Competitors 14
SPAGO Nanomedical AB, Key Employees 15

List of Figures
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SPAGO Nanomedical AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SPAGO Nanomedical AB, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[SPAGO Nanomedical AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Nihon Kohden Corp (6849):医療機器:M&Aディール及び事業提携情報
    Summary Nihon Kohden Corp (Nihon Kohden) is a provider of medical electronic equipment to support treatment in clinical areas of emergency response; testing, diagnosis, treatment, and rehabilitation. Its major products include patient monitors, electroencephalographs, evoked potential and electromyo …
  • Direct Flow Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Direct Flow Medical Inc (Direct Flow) is a medical device company that develops novel transcatheter heart valve technologies. The company provides transcatheter aortic valve implantation device without contrast. It also provides direct flow medical system, a technology for controlled and rel …
  • Rockwell Collins Inc:戦略・SWOT・企業財務分析
    Rockwell Collins Inc - Strategy, SWOT and Corporate Finance Report Summary Rockwell Collins Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Asian Citrus Holdings Ltd. (73):企業の財務・戦略的SWOT分析
    Asian Citrus Holdings Ltd. (73) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • ARK Diagnostics Inc:企業の製品パイプライン分析
    Summary ARK Diagnostics Inc (ARK Diagnostics) is a developer, manufacturer and commercializer of in vitro diagnostic immunoassay products. The company's products include protease inhibitors, levetiracetam assay, topiramate assay, non-nucleoside reverse transcriptase inhibitors, gabapentin assay, lam …
  • Ascendant Group Limited (AGL.BH):企業の戦略的SWOT分析
    Ascendant Group Limited (AGL.BH) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Tanner Pharma Group Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tanner Pharma Group Inc (Tanner Pharma), a subsidiary of Bourne Capital Partners LLC, is a pharmaceutical services company which offers distribution, licensing and commercialization of health care products. The company offers clinical trial sourcing solutions, regulatory affairs management a …
  • Touchstone Exploration Inc (TXP):企業の財務・戦略的SWOT分析
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd is an upstream oil and gas exploration and production company that explores, produces, and develops, oil and gas properties in Trinidad and Tobago. The company holds interests, owns, and operates projects such as WD-4 …
  • Ecobliss Holding BV:企業の戦略・SWOT・財務情報
    Ecobliss Holding BV - Strategy, SWOT and Corporate Finance Report Summary Ecobliss Holding BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tokyo Electric Power Company Holdings Incorporated:発電所・企業SWOT分析
    Tokyo Electric Power Company Holdings Incorporated – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysi …
  • H.I.G. Capital LLC:企業の戦略的SWOT分析
    H.I.G. Capital LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Biomerica Inc (BMRA):企業の財務・戦略的SWOT分析
    Biomerica Inc (BMRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Prairie Land Electric Cooperative Inc:企業の戦略的SWOT分析
    Prairie Land Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Galliford Try Plc (GFRD):企業の財務・戦略的SWOT分析
    Galliford Try Plc (GFRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Vector Ltd (VCT):電力:M&Aディール及び事業提携情報
    Summary Vector Ltd (Vector), a subsidiary of Entrust, is a utility network provider. It offers power and telecommunication services. The company distributes electricity and gas in Auckland; stores and processes, and sells natural gas and LPG; and deploys electricity and gas meters to homes and busin …
  • Center For Diagnostic Imaging Inc-医療機器分野:企業M&A・提携分析
    Summary Center For Diagnostic Imaging Inc (CDI), a subsidiary of InSight Health Services Holdings Corp is a healthcare center that patient care services. The center offers upright MRI, diagnostic breast imaging exams, breast biopsies, open CDI vascular care, open upright MRI, nuclear medicine, ultra …
  • Contact Energy Ltd (CEN):企業の財務・戦略的SWOT分析
    Contact Energy Ltd (CEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Tenneco Inc. (TEN):企業の財務・戦略的SWOT分析
    Tenneco Inc. (TEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Imperial College London-製薬・医療分野:企業M&A・提携分析
    Summary Imperial College London (Imperial) is a research university that offers educational services. The university provides undergraduate and postgraduate courses. It offers courses in the field of science and technology, agriculture, business, the humanities, and medicine. It conducts clinical tr …
  • Rubis SCA (RUI):石油・ガス:M&Aディール及び事業提携情報
    Summary Rubis SCA (Rubis) is an independent downstream company that carries out the storage, distribution and trading of bulk petroleum and chemical products. Its product portfolio includes fuel oil, liquefied petroleum gas (LPG), gasoline, diesel, home heating oil, chemical products, edible oils, m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆